Attention for Chapter 234:
From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Chapter title |
From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease
|
Chapter number |
234 |
Book title |
NeuroPsychopharmacotherapy
|
Published by |
Springer, Cham, January 2022
|
DOI |
10.1007/978-3-030-62059-2_234 |
Book ISBNs |
978-3-03-062058-5, 978-3-03-062059-2
|
Authors |
Zheng, Hailin, Amit, Tamar, Bar-Am, Orit, Fridkin, Mati, Mandel, Silvia A., Youdim, Moussa B. H.
|
Mendeley readers
Mendeley readers
Geographical breakdown
Country |
Count |
As % |
Unknown |
12 |
100% |
Demographic breakdown
Readers by professional status |
Count |
As % |
Student > Postgraduate |
3 |
25% |
Student > Master |
3 |
25% |
Student > Ph. D. Student |
2 |
17% |
Student > Doctoral Student |
1 |
8% |
Unknown |
3 |
25% |
Readers by discipline |
Count |
As % |
Pharmacology, Toxicology and Pharmaceutical Science |
3 |
25% |
Medicine and Dentistry |
3 |
25% |
Psychology |
2 |
17% |
Neuroscience |
1 |
8% |
Unknown |
3 |
25% |